Autoimmune Encephalitis Clinical Trials in Paris
3 recruitingParis, France
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis
NMDAR Autoimmune EncephalitisLGI1 Autoimmune Encephalitis
Hoffmann-La Roche152 enrolled93 locationsNCT05503264
Recruiting
Not Applicable
Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism
Autoimmune Encephalitis
Assistance Publique - Hôpitaux de Paris56 enrolled1 locationNCT06079294
Recruiting
Not Applicable
Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection
Paraneoplastic Neurological Syndromes or Autoimmune Encephalitis
Hospices Civils de Lyon3,500 enrolled62 locationsNCT05198661